Cargando…

Differentially Methylated DNA Regions and Left Ventricular Hypertrophy in African Americans: A HyperGEN Study

Left ventricular (LV) hypertrophy (LVH) is an independent risk factor for cardiovascular disease, and African Americans experience a disparate high risk of LVH. Genetic studies have identified potential candidate genes and variants related to the condition. Epigenetic modifications may continue to h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jones, Alana C., Patki, Amit, Claas, Steven A., Tiwari, Hemant K., Chaudhary, Ninad S., Absher, Devin M., Lange, Leslie A., Lange, Ethan M., Zhao, Wei, Ratliff, Scott M., Kardia, Sharon L. R., Smith, Jennifer A., Irvin, Marguerite R., Arnett, Donna K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9601679/ https://www.ncbi.nlm.nih.gov/pubmed/36292585 http://dx.doi.org/10.3390/genes13101700

Ejemplares similares

A 6-CpG validated methylation risk score model for metabolic syndrome: The HyperGEN and GOLDN studies
por: Hidalgo, Bertha A., et al.
Publicado: (2021)

An evaluation of the metabolic syndrome in the HyperGEN study
por: Kraja, Aldi T, et al.
Publicado: (2005)

Genome-wide joint SNP and CNV analysis of aortic root diameter in African Americans: the HyperGEN study
por: Wineinger, Nathan E, et al.
Publicado: (2011)

Association of Comorbidity Burden With Abnormal Cardiac Mechanics: Findings From the HyperGEN Study
por: Selvaraj, Senthil, et al.
Publicado: (2014)

PCSK9 variation and association with blood pressure in African Americans: preliminary findings from the HyperGEN and REGARDS studies
por: Tran, Ngan T., et al.
Publicado: (2015)

Copy number variations associated with obesity related traits in African Americans: a joint analysis between GENOA and HyperGEN
por: Zhao, Wei, et al.
Publicado: (2012)

Genome-Wide Detection of Allele Specific Copy Number Variation Associated with Insulin Resistance in African Americans from the HyperGEN Study
por: Irvin, Marguerite R., et al.
Publicado: (2011)

The role of SNP-loop diuretic interactions in hypertension across ethnic groups in HyperGEN
por: de Las Fuentes, Lisa, et al.
Publicado: (2013)

Genome-wide association study identifies single-nucleotide polymorphism in KCNB1 associated with left ventricular mass in humans: The HyperGEN Study
por: Arnett, Donna K, et al.
Publicado: (2009)

An investigation of the effects of lipid-lowering medications: genome-wide linkage analysis of lipids in the HyperGEN study
por: Wu, Jun, et al.
Publicado: (2007)

AGT M235T Genotype/Anxiety Interaction and Gender in the HyperGEN Study
por: Knox, Sarah S., et al.
Publicado: (2010)

Identification of a pleiotropic locus on chromosome 7q for a composite left ventricular wall thickness factor and body mass index: the HyperGEN Study
por: Tang, Weihong, et al.
Publicado: (2009)

Epistatic effects of ACE I/D and AGT gene variants on left ventricular mass in hypertensive patients: The HyperGEN Study
por: Lynch, Amy I., et al.
Publicado: (2011)

Metabolite profiles and DNA methylation in metabolic syndrome: a two-sample, bidirectional Mendelian randomization
por: Jones, Alana C., et al.
Publicado: (2023)

Genomics of Post-Prandial Lipidomic Phenotypes in the Genetics of Lipid Lowering Drugs and Diet Network (GOLDN) Study
por: Irvin, Marguerite R., et al.
Publicado: (2014)

Genetic Contributors of Incident Stroke in 10,700 African Americans With Hypertension: A Meta-Analysis From the Genetics of Hypertension Associated Treatments and Reasons for Geographic and Racial Differences in Stroke Studies
por: Armstrong, Nicole D., et al.
Publicado: (2021)

Epigenome-wide association study of metabolic syndrome in African-American adults
por: Akinyemiju, Tomi, et al.
Publicado: (2018)

Metabolic and inflammatory biomarkers are associated with epigenetic aging acceleration estimates in the GOLDN study
por: Irvin, Marguerite R., et al.
Publicado: (2018)

Neighborhood Walkability as a Predictor of Incident Hypertension in a National Cohort Study
por: Jones, Alana C., et al.
Publicado: (2021)

The effects of angiotensinogen gene polymorphisms on cardiovascular disease outcomes during antihypertensive treatment in the GenHAT study
por: Do, Anh N., et al.
Publicado: (2014)

Boundary value problems for hypergenic function vectors
por: Zhang, Guiling, et al.
Publicado: (2018)

The effects of genes implicated in cardiovascular disease on blood-pressure response to treatment among treatment-naïve hypertensive African Americans in the GenHAT study
por: Do, Anh N, et al.
Publicado: (2016)

Genetic Contributors of Efficacy and Adverse Metabolic Effects of Chlorthalidone in African Americans from the Genetics of Hypertension Associated Treatments (GenHAT) Study
por: Armstrong, Nicole D., et al.
Publicado: (2022)

Genetic and Adverse Health Outcome Associations with Treatment Resistant Hypertension in GenHAT
por: Lynch, Amy I., et al.
Publicado: (2013)

Whole-Exome Sequencing and hiPSC Cardiomyocyte Models Identify MYRIP, TRAPPC11, and SLC27A6 of Potential Importance to Left Ventricular Hypertrophy in an African Ancestry Population
por: Irvin, Marguerite R., et al.
Publicado: (2021)

A PheWAS study of a large observational epidemiological cohort of African Americans from the REGARDS study
por: Zhao, Xueyan, et al.
Publicado: (2019)

SMOC2 gene interacts with APOL1 in the development of end-stage kidney disease: A genome-wide association study
por: Chaudhary, Ninad S., et al.
Publicado: (2022)

Genomics of Postprandial Lipidomics in the Genetics of Lipid-Lowering Drugs and Diet Network Study
por: Irvin, Marguerite R., et al.
Publicado: (2021)

Epigenome-Wide Association Study of Fasting Measures of Glucose, Insulin, and HOMA-IR in the Genetics of Lipid Lowering Drugs and Diet Network Study
por: Hidalgo, Bertha, et al.
Publicado: (2014)

Heritable DNA Methylation in CD4(+) Cells among Complex Families Displays Genetic and Non-Genetic Effects
por: Day, Kenneth, et al.
Publicado: (2016)

Lipid changes due to fenofibrate treatment are not associated with changes in DNA methylation patterns in the GOLDN study
por: Das, Mithun, et al.
Publicado: (2015)

Epigenome-wide association study of triglyceride postprandial responses to a high-fat dietary challenge
por: Lai, Chao-Qiang, et al.
Publicado: (2016)

Data for GAW20: genome-wide DNA sequence variation and epigenome-wide DNA methylation before and after fenofibrate treatment in a family study of metabolic phenotypes
por: Aslibekyan, Stella, et al.
Publicado: (2018)

Genetic variants modify the effect of age on APOE methylation in the Genetics of Lipid Lowering Drugs and Diet Network study
por: Ma, Yiyi, et al.
Publicado: (2015)

Age and sex are associated with the plasma lipidome: findings from the GOLDN study
por: Slade, Emily, et al.
Publicado: (2021)

Association of DNA Methylation at CPT1A Locus with Metabolic Syndrome in the Genetics of Lipid Lowering Drugs and Diet Network (GOLDN) Study
por: Das, Mithun, et al.
Publicado: (2016)

Whole-exome Sequencing and an iPSC-Derived Cardiomyocyte Model Provides a Powerful Platform for Gene Discovery in Left Ventricular Hypertrophy
por: Zhi, D., et al.
Publicado: (2012)

Changes in lipidomic profile by anti-retroviral treatment regimen: An ACTG 5257 ancillary study
por: Chaudhary, Ninad S., et al.
Publicado: (2021)

An Amish founder population reveals rare-population genetic determinants of the human lipidome
por: Montasser, May E., et al.
Publicado: (2022)

Tracing and Assessing the Evolution of Clinical Guidelines
por: Arnett, Donna K., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lkpqjpdpj9krhelsqa29vfa7sn